ADAMAS Insights

Make the right decisions. Driven by data, based on actionable insights.

Become the first to discover our data

More data, less risk

Exclusively access data from more than 1,500 real-world recent GxP audits, visualised and organised intuitively. You will be able to instantly see data-quality trends, identify the strengths and weaknesses of your systems and processes, and take action – reducing risk and safeguarding your organisation.


Discover how ADAMAS Insights can make your organisation better

Identify Trends

See how data quality varies and aligns across regions, countries, clients, protocols and audited areas

Reduce Risk

Identify potential risks and put strategies in place to reduce or eliminate them

Benchmark Data

Learn how your data compares to that of over 700 other companies in more than 100 countries

Gain Focus

Pinpoint and address the most pressing potential issues in your organisation, allocating time and resource effectively and efficiently

Unlock Success

Achieve your goals with complete peace of mind by putting meaningful risk-mitigation strategies in place

Register your interest today and be first to get your hands on the data

Be the first to get ADAMAS Insights

Want to become one of the first organisations to access our exclusive data? Get going and start reducing risk today.

Help us to help you

We want ADAMAS Insights to be as helpful, easy-to-use and accessible as possible for your organisation. Take our short survey and help us deliver the specific services you need.

The ADAMAS Corporate Brochure 2016


Brochure – Please download the ADAMAS brochure describing our QA services and contact details.

Regulatory Environment


The development of medicines is the most regulated industry in the world, and compliance at each stage of the research and development process, as well as after licensing, is critical to ensuring high quality and safe medicines reach patients in a timely manner.



ADAMAS’s consultants have expertise across the G’X’Ps in pre-clinical, clinical and post-licensing areas. They have worked across many different therapeutic areas and product types including oncology, vaccines, biologics, medical devices and gene therapy. As a company we have developed close partnerships with our clients to support them in their development programmes and post-licensing activities, and to guide them successfully through their worldwide regulatory inspections.


How to be a Clinical Auditor


‘So you want to be a Clinical Auditor?’, an article written by CEO Dr. Patricia Fitzgerald.

Benchmarking Data


Please download our benchmarking data sheet, to see how these data compare with your own performance. To discuss a more detailed report, or analysis of a data subset, please get in touch.

Is your QMS compliant?


Is your QMS compliant to the upcoming ICH E6 Addendum? Download our 5-point checklist

ICH (E6) R2 Addendum - Step 4


Please enter your details to complete the download.



Want to become one of the first businesses to access our exclusive data?
Get going and start reducing risk today. Pre register now.